Guj. Terce Labs, a company in the Pharmaceuticals industry, reported revenue of ₹13 crore and net profit of ₹1.32 crore for the September 2026 quarter.
Guj. Terce Labs. (BSE: GUJTERC) closed at ₹41.00 on 20 Nov 2026, down 4.8% over the past year. Its market capitalisation is ₹32 crore and it trades at 14.9 times earnings.
Incorporated in 1985. Gujarat Terce Laboratories Ltd is engaged in development, manufacturing, marketing and distribution of medicines, healthcare products and branded generics
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.